What do Analysts Say about Valeritas Holdings, Inc.(NASDAQ:VLRX): Syneos Health, Inc.(NASDAQ:SYNH)

0
1

Valeritas Holdings, Inc. (VLRX) will report its next earnings on Nov 12 AMC. The company reported the earnings of $-1.91/Share in the last quarter where the estimated EPS by analysts was $-2.52/share. The difference between the expected and actual EPS was $0.61/share, which represents an Earnings surprise of 24.2%.

Many analysts are providing their Estimated Earnings analysis for Valeritas Holdings, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-1.58/share. These analysts have also projected a Low Estimate of $-1.67/share and a High Estimate of $-1.5/share.

In case of Revenue Estimates, 2 analysts have provided their consensus Average Revenue Estimates for Valeritas Holdings, Inc. as 9.25 Million. According to these analysts, the Low Revenue Estimate for Valeritas Holdings, Inc. is 9.2 Million and the High Revenue Estimate is 9.3 Million. The company had Year Ago Sales of 6.89 Million.

Some buy side analysts are also providing their Analysis on Valeritas Holdings, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Valeritas Holdings, Inc. might touch $10 high while the Average Price Target and Low price Target is $7.5 and $5 respectively.

Valeritas Holdings, Inc. closed its last trading session at $1.65 with the loss of -1.21%. The Market Capitalization of the company stands at 13.53 Million. The Company has 52-week high of $11.39 and 52-week low of $1.10. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 8.45% where SMA50 and SMA200 are 13.43% and -57.38% respectively. The Company Touched its 52-Week High on 03/05/19 and 52-Week Low on 10/14/19.

The Relative Volume of the company is 0.13 and Average Volume (3 months) is 248.19 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -97.3%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is -76.9%.

While looking at the Stock’s Performance, Valeritas Holdings, Inc. currently shows a Weekly Performance of 15.6%, where Monthly Performance is 10.14%, Quarterly performance is -10.93%, 6 Months performance is -55.83% and yearly performance percentage is -78.83%. Year to Date performance value (YTD perf) value is -74.96%. The Stock currently has a Weekly Volatility of 6.68% and Monthly Volatility of 8.02%.

Syneos Health, Inc. (SYNH) will report its next earnings on Oct 31 BMO. The company reported the earnings of $0.87/Share in the last quarter where the estimated EPS by analysts was $0.82/share. The difference between the expected and actual EPS was $0.05/share, which represents an Earnings surprise of 6.1%.

Many analysts are providing their Estimated Earnings analysis for Syneos Health, Inc. and for the current quarter 12 analysts have projected that the stock could give an Average Earnings estimate of $1.01/share. These analysts have also projected a Low Estimate of $0.97/share and a High Estimate of $1.03/share.

In case of Revenue Estimates, 12 analysts have provided their consensus Average Revenue Estimates for Syneos Health, Inc. as 1.19 Billion. According to these analysts, the Low Revenue Estimate for Syneos Health, Inc. is 1.18 Billion and the High Revenue Estimate is 1.2 Billion. The company had Year Ago Sales of 1.15 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for SYNH to be 6.3%. They are projecting Next Quarter growth of 28.81%. For the next 5 years, Syneos Health, Inc. is expecting Growth of 13.03% per annum, whereas in the past 5 years the growth was 11.85% per annum.

Some buy side analysts are also providing their Analysis on Syneos Health, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Syneos Health, Inc. might touch $68 high while the Average Price Target and Low price Target is $59.17 and $48 respectively.

Syneos Health, Inc. closed its last trading session at $55.17 with the loss of -0.46%. The Market Capitalization of the company stands at 5.74 Billion. The Company has 52-week high of $56.34 and 52-week low of $36.26. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 8.05% where SMA50 and SMA200 are 4.54% and 10.75% respectively. The Company Touched its 52-Week High on 02/25/19 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.39 and Average Volume (3 months) is 419.48 million. The company’s P/E (price to earnings) ratio is 69.68 and Forward P/E ratio of 15.34.

The company shows its Return on Assets (ROA) value of 1.2%. The Return on Equity (ROE) value stands at 3%. While it’s Return on Investment (ROI) value is 2.1%.

While looking at the Stock’s Performance, Syneos Health, Inc. currently shows a Weekly Performance of 6.23%, where Monthly Performance is 1.8%, Quarterly performance is 4.53%, 6 Months performance is 34.55% and yearly performance percentage is 7.62%. Year to Date performance value (YTD perf) value is 39.54%. The Stock currently has a Weekly Volatility of 2.37% and Monthly Volatility of 2.80%.

SHARE